Total trials
71
Active
16
Phase 3
1
Total enrollment
8,224
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Application of 5-fluorouracil | — | — | — | — | — | 1 | |
| Application of Carnoy solution | — | — | — | — | — | 1 | |
| Methylprednisolone | — | — | — | — | — | 1 |
Next readouts
- 2025-06-10
- 2027-01
Top conditions
- Periodontitis6
- Local Anesthesia3
- Hepatocellular Carcinoma (HCC)2
- Liver Neoplasms2
- Breast Cancer2
- Post Operative Pain2
- Low Back Pain2
- Carotid Artery Stenosis2
Frequently asked questions about University of Belgrade
- How many clinical trials does University of Belgrade have on ClinicalTrials.gov?
- University of Belgrade is listed as the lead sponsor on 71 clinical trials in ClinicalTrials.gov, 16 of which are currently active (recruiting, enrolling, or ongoing).
- How many of University of Belgrade's trials are in Phase 3?
- 1 of University of Belgrade's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does University of Belgrade focus on?
- University of Belgrade's most-studied conditions on ClinicalTrials.gov are Periodontitis, Local Anesthesia, Hepatocellular Carcinoma (HCC), Liver Neoplasms, Breast Cancer.
- When are University of Belgrade's next clinical trial readouts?
- University of Belgrade has 2 upcoming primary-completion readouts tracked here; the soonest is “Usage of 5-fluorouracil and Carnoy's Solution in Surgical Treatment of Odontogenic Keratocysts”, expected around 2025-06-10.